☰

Monica J. Turk, Ph.D. - Publications

Affiliations: 
University of California, Santa Barbara, Santa Barbara, CA, United States 
Area:
Interactional linguistics, conversation and grammar, East Asian linguistics
Tree Info Similar researchers PubMed Report error

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Clancy-Thompson E, Perekslis TJ, Croteau W, Alexander MP, Chabanet TB, Turk MJ, Huang YH, Mullins DW. Melanoma induces, and adenosine suppresses, CXCR3-cognate chemokine production and T cell infiltration of lungs bearing metastatic-like disease. Cancer Immunology Research. PMID 26048575 DOI: 10.1158/2326-6066.Cir-15-0015  0.38
2015 Steinberg SM, Turk MJ. BRAF-inhibition and tumor immune suppression. Oncoimmunology. 4: e988039. PMID 25949884 DOI: 10.4161/2162402X.2014.988039  0.416
2014 Steinberg SM, Zhang P, Malik BT, Boni A, Shabaneh TB, Byrne KT, Mullins DW, Brinckerhoff CE, Ernstoff MS, Bosenberg MW, Turk MJ. BRAF inhibition alleviates immune suppression in murine autochthonous melanoma. Cancer Immunology Research. 2: 1044-50. PMID 25183499 DOI: 10.1158/2326-6066.Cir-14-0074  0.497
2014 Toraya-Brown S, Sheen MR, Zhang P, Chen L, Baird JR, Demidenko E, Turk MJ, Hoopes PJ, Conejo-Garcia JR, Fiering S. Local hyperthermia treatment of tumors induces CD8(+) T cell-mediated resistance against distal and secondary tumors. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 1273-85. PMID 24566274 DOI: 10.1016/J.Nano.2014.01.011  0.391
2014 Byrne KT, Zhang P, Steinberg SM, Turk MJ. Autoimmune vitiligo does not require the ongoing priming of naive CD8 T cells for disease progression or associated protection against melanoma. Journal of Immunology (Baltimore, Md. : 1950). 192: 1433-9. PMID 24403535 DOI: 10.4049/jimmunol.1302139  0.347
2013 Black CC, Turk MJ, Dragnev K, Rigas JR. Adenocarcinoma contains more immune tolerance regulatory t-cell lymphocytes (versus squamous carcinoma) in non-small-cell lung cancer. Lung. 191: 265-70. PMID 23494387 DOI: 10.1007/s00408-013-9455-7  0.436
2013 Baird JR, Byrne KT, Lizotte PH, Toraya-Brown S, Scarlett UK, Alexander MP, Sheen MR, Fox BA, Bzik DJ, Bosenberg M, Mullins DW, Turk MJ, Fiering S. Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge. Journal of Immunology (Baltimore, Md. : 1950). 190: 469-78. PMID 23225891 DOI: 10.4049/Jimmunol.1201209  0.313
2013 Toraya-Brown S, Sheen MR, Baird JR, Barry S, Demidenko E, Turk MJ, Hoopes PJ, Conejo-Garcia JR, Fiering S. Phagocytes mediate targeting of iron oxide nanoparticles to tumors for cancer therapy. Integrative Biology : Quantitative Biosciences From Nano to Macro. 5: 159-71. PMID 22935885 DOI: 10.1039/C2Ib20180A  0.338
2012 Guo Y, Pino-Lagos K, Ahonen CA, Bennett KA, Wang J, Napoli JL, Blomhoff R, Sockanathan S, Chandraratna RA, Dmitrovsky E, Turk MJ, Noelle RJ. A retinoic acid--rich tumor microenvironment provides clonal survival cues for tumor-specific CD8(+) T cells. Cancer Research. 72: 5230-9. PMID 22902413 DOI: 10.1158/0008-5472.Can-12-1727  0.343
2011 Côté AL, Byrne KT, Steinberg SM, Zhang P, Turk MJ. Protective CD8 memory T cell responses to mouse melanoma are generated in the absence of CD4 T cell help. Plos One. 6: e26491. PMID 22046294 DOI: 10.1371/journal.pone.0026491  0.338
2011 Byrne KT, Turk MJ. New perspectives on the role of vitiligo in immune responses to melanoma. Oncotarget. 2: 684-94. PMID 21911918  0.444
2011 Byrne KT, Côté AL, Zhang P, Steinberg SM, Guo Y, Allie R, Zhang W, Ernstoff MS, Usherwood EJ, Turk MJ. Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma. The Journal of Clinical Investigation. 121: 1797-809. PMID 21540555 DOI: 10.1172/Jci44849  0.408
2011 Côté AL, Zhang P, O'Sullivan JA, Jacobs VL, Clemis CR, Sakaguchi S, Guevara-Patiño JA, Turk MJ. Stimulation of the glucocorticoid-induced TNF receptor family-related receptor on CD8 T cells induces protective and high-avidity T cell responses to tumor-specific antigens. Journal of Immunology (Baltimore, Md. : 1950). 186: 275-83. PMID 21106849 DOI: 10.4049/jimmunol.1001308  0.457
2010 Zhang W, Zhang T, Turk MJ, Usherwood EJ. A persistent virus vector confers superior anti-tumor immunity, compared with a non-persistent vector. Cancer Immunology, Immunotherapy : Cii. 59: 707-13. PMID 19921188 DOI: 10.1007/S00262-009-0790-8  0.397
2009 Nesbeth Y, Scarlett U, Cubillos-Ruiz J, Martinez D, Engle X, Turk MJ, Conejo-Garcia JR. CCL5-mediated endogenous antitumor immunity elicited by adoptively transferred lymphocytes and dendritic cell depletion. Cancer Research. 69: 6331-8. PMID 19602595 DOI: 10.1158/0008-5472.Can-08-4329  0.483
2009 Huarte E, Fisher J, Turk MJ, Mellinger D, Foster C, Wolf B, Meehan KR, Fadul CE, Ernstoff MS. Ex vivo expansion of tumor specific lymphocytes with IL-15 and IL-21 for adoptive immunotherapy in melanoma. Cancer Letters. 285: 80-8. PMID 19501956 DOI: 10.1016/j.canlet.2009.05.003  0.331
2008 Bak SP, Alonso A, Turk MJ, Berwin B. Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression. Molecular Immunology. 46: 258-68. PMID 18824264 DOI: 10.1016/j.molimm.2008.08.266  0.426
2008 Côté AL, Usherwood EJ, Turk MJ. Tumor-specific T-cell memory: clearing the regulatory T-cell hurdle. Cancer Research. 68: 1614-7. PMID 18339838 DOI: 10.1158/0008-5472.Can-07-6012  0.404
2008 Ahonen CL, Wasiuk A, Fuse S, Turk MJ, Ernstoff MS, Suriawinata AA, Gorham JD, Kedl RM, Usherwood EJ, Noelle RJ. Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines. Blood. 111: 3116-25. PMID 18202224 DOI: 10.1182/Blood-2007-09-114371  0.433
2007 Zhang P, Côté AL, de Vries VC, Usherwood EJ, Turk MJ. Induction of postsurgical tumor immunity and T-cell memory by a poorly immunogenic tumor. Cancer Research. 67: 6468-76. PMID 17616708 DOI: 10.1158/0008-5472.Can-07-1264  0.441
2006 Uchi H, Stan R, Turk MJ, Engelhorn ME, Rizzuto GA, Goldberg SM, Wolchok JD, Houghton AN. Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo. Advances in Immunology. 90: 215-41. PMID 16730265 DOI: 10.1016/S0065-2776(06)90006-6  0.389
2006 Cohen AD, Diab A, Perales MA, Wolchok JD, Rizzuto G, Merghoub T, Huggins D, Liu C, Turk MJ, Restifo NP, Sakaguchi S, Houghton AN. Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity. Cancer Research. 66: 4904-12. PMID 16651447 DOI: 10.1158/0008-5472.Can-05-2813  0.43
2006 Guevara-Patiño JA, Engelhorn ME, Turk MJ, Liu C, Duan F, Rizzuto G, Cohen AD, Merghoub T, Wolchok JD, Houghton AN. Optimization of a self antigen for presentation of multiple epitopes in cancer immunity. The Journal of Clinical Investigation. 116: 1382-90. PMID 16614758 DOI: 10.1172/Jci25591  0.386
2004 Turk MJ, Guevara-Patiño JA, Rizzuto GA, Engelhorn ME, Sakaguchi S, Houghton AN. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. The Journal of Experimental Medicine. 200: 771-82. PMID 15381730 DOI: 10.1084/Jem.20041130  0.489
2003 Guevara-Patiño JA, Turk MJ, Wolchok JD, Houghton AN. Immunity to cancer through immune recognition of altered self: studies with melanoma. Advances in Cancer Research. 90: 157-77. PMID 14710950 DOI: 10.1016/S0065-230X(03)90005-4  0.423
2003 Ramirez-Montagut T, Turk MJ, Wolchok JD, Guevara-Patino JA, Houghton AN. Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity. Oncogene. 22: 3180-7. PMID 12789294 DOI: 10.1038/Sj.Onc.1206462  0.493
2002 Turk MJ, Wolchok JD, Guevara-Patino JA, Goldberg SM, Houghton AN. Multiple pathways to tumor immunity and concomitant autoimmunity. Immunological Reviews. 188: 122-35. PMID 12445286 DOI: 10.1034/J.1600-065X.2002.18811.X  0.456
Show low-probability matches.